| 1 |
Alkyl and Aryl Derivatives Based on p-Coumaric Acid Modification and Inhibitory Action against Leishmania braziliensis and Plasmodium falciparum |
|
| | Susiany P. Lopes,Lina M. Yepes,Yunierkis Pérez-Castillo,Sara M. Robledo,Damião P. de Sousa | | | Molecules. 2020; 25(14): 3178 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Promising antileishmanial effectiveness of doxorubicin and Doxil against Leishmania major : An in vitro assay |
|
| | Azar Shokri,Javad Akhtari,Masoud Keighobadi,Mahdi Fakhar,Saeed Hosseini Teshnizi,Saeed Emami,Sajede Sadjjadian | | | Asian Pacific Journal of Tropical Medicine. 2017; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Case Report: No Response to Liposomal Daunorubicin in a Patient with Drug-Resistant HIV-Associated Visceral Leishmaniasis |
|
| | Nicholas J. Gow,Robert N. Davidson,Rob Ticehurst,Andrew Burns,Mark G. Thomas,Carlos Franco-Paredes | | | PLOS Neglected Tropical Diseases. 2015; 9(8): e0003983 | | | [Pubmed] [Google Scholar] [DOI] | |
|
